The stratified approach includes mining masses of patient data to deliver actionable items, relating both to risk profiling and optimal testing. The whole person is emphasized, including genetics and co-morbidities, as well as the home and work environments. The result moves from statistical analysis to causal analysis, and treats disease states as a process.
Dr. Liebman is President and Managing Director of Strategic Medicine, Inc. Previously, he was Executive Director of the Windber Research Institute and Director of Computational Biology and Biomedical Informatics at the Abramson Family Cancer Research Institute of the University of Pennsylvania Cancer Center.
Dr. Liebman serves on 12 international scientific advisory boards and is an Invited Professor at the Shanghai Center for Bioinformatics Technology.